The fish oil supplements studied, which contain high levels of the omega-3 fatty acids EPA and DHA, were preliminarily linked to a 32 percent drop in the risk of developing invasive ductal carcinoma (the most common type of breast cancer) among post-menopausal women. Researchers from the Fred Hutchison Cancer Research Center in Seattle recently published results of their study in Cancer Epidemiology, Biomarkers and Prevention. The scientists found fish oil did not seem to affect the risk of lobular cancer
Statement on Fred Hutchison Omega-3 / Breast Cancer Study
“The possibility that regular use of fish oil supplements could help reduce the risk of breast cancer, is of course, both potentially exciting as well as intriguing,” said Liz Thompson, senior vice president of Medical and Scientific Affairs for Susan G. Komen for the Cure®. “These early findings demonstrate the need for follow-up studies. In fact, Komen for the Cure is already investing $7.5 million in a major study at Pennsylvania State University's School of Medicine looking at how fish oils may be combined with the drug raloxifene to prevent breast cancer. In the meantime, we suggest women check with their health care providers about the pros and cons of using these and other supplements.”
The fish oil supplements studied, which contain high levels of the omega-3 fatty acids EPA and DHA, were preliminarily linked to a 32 percent drop in the risk of developing invasive ductal carcinoma (the most common type of breast cancer) among post-menopausal women. Researchers from the Fred Hutchison Cancer Research Center in Seattle recently published results of their study in Cancer Epidemiology, Biomarkers and Prevention. The scientists found fish oil did not seem to affect the risk of lobular cancer
0 Comments
Leave a Reply. |
AuthorMy name is Sue Kilburn and I am a clinical nurse breast cancer educator at the Yolanda G. Barco Oncology Institute in Meadville, Pennsylvania. Archives
March 2015
Categories |